446 results on '"Kostman, Jay"'
Search Results
102. Retention of Functional DC-NK Cross-Talk Following up to 18 Weeks Therapy Interruptions in Chronically Suppressed HIV Type 1+ Subjects
103. Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia
104. Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
105. HIV Replication Capacity Is an Independent Predictor of Disease Progression in Persons With Untreated Chronic HIV Infection
106. Inability of Plasmacytoid Dendritic Cells To Directly Lyse HIV-Infected Autologous CD4 + T Cells despite Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
107. The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients
108. Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance
109. Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection
110. Evidence of a Decrease in CD4 Recovery Once Back on Antiretroviral Therapy After Sequential ≥6 Weeks Antiretroviral Therapy Interruptions
111. Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes
112. Short Communication: HIV Type 1 Viremia on ART Is Positively Associated with Polyclonal T Cell Proliferation in Subjects with T Cell IFN-γ Secretion Levels Comparable to Those of Uninfected Subjects
113. Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment
114. Incidence and Risk Factors for Weight Loss During Dual HIV/Hepatitis C Virus Therapy
115. Prevalence, Risk Factors, and Outcomes for Occult Hepatitis B Virus Infection Among HIV-Infected Patients
116. Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein.
117. Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1+ patients.
118. IL-13 Acutely Augments HIV-Specific and Recall Responses from HIV-1-Infected Subjects In Vitro by Modulating Monocytes
119. Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
120. Recruitment and Baseline Epidemiologic Profile of Participants in the First Phase 3 HIV Vaccine Efficacy Trial
121. Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon α-2b+ full-course vs. 16-week delayed ribavirin
122. Hypereosinophilia associated with cardiac rhabdomyosarcoma
123. Sustained Impairment of IFN-γ Secretion in Suppressed HIV-Infected Patients Despite Mature NK Cell Recovery: Evidence for a Defective Reconstitution of Innate Immunity
124. Persistent Decreases in Blood Plasmacytoid Dendritic Cell Number and Function Despite Effective Highly Active Antiretroviral Therapy and Increased Blood Myeloid Dendritic Cells in HIV-Infected Individuals
125. Chapter 16: Emerging Infectious Diseases.
126. Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection
127. IL-13 and IFN-γ Secretion by Activated T Cells in HIV-1 Infection Associated with Viral Suppression and a Lack of Disease Progression
128. Laboratory diagnosis of rickettsial diseases
129. The Comparative in vitro Activity of Clinafloxacin and Other Antimicrobials against Vancomycin-Susceptible and Vancomycin-Resistant Enterococci
130. Hypersensitivity Reaction During Prolonged Use of Piperacillin/Tazobactam in Treatment of Osteomyelitis
131. Investigation of a Pseudo-Outbreak of Orthopedic Infections Caused byPseudomonas aeruginosa
132. Molecular techniques in the diagnosis of sexually transmitted diseases
133. The detection of positive blood cultures by the bactec NR660 the clinical importance of four-day versus seven-day testing
134. Infections with Chryseomonas luteola (CDC Group Ve-1) and Flavimonas oryzihabitans (CDC Group Ve-2) in Neurosurgical Patients
135. Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection.
136. Natural History of Patients with Low-Level HIV Viremia on Antiretroviral Therapy.
137. Infections with Chryseomonas luteola (CDC Group Ve-1) and Flavimonas oryzihabitans (CDC Group Ve-2) in Neurosurgical Patients.
138. Invasive Colitis and Hepatitis Due to Previously Uncharacterized Spirochetes in Patients with Advanced Human Immunodeficiency Virus Infection.
139. Invasive Haemophilus influenzae Infections in Older Children and Adults in Seattle.
140. HIV-1-Specific CD4+T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption
141. Efficacy and Safety of Twice-Daily versus Three-Times Daily Saquinavir Soft Gelatin Capsules as Part of Triple Combination Therapy for HIV-1 Infection
142. Granulomatous Tophaceous Gout Mimicking Tuberculous Tenosynovitis: Report of Two Cases.
143. Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people.
144. Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count >= 300 cells/mu L who were assigned to 7.5 MIU interleukin-2
145. Additional file 1 of Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection
146. Additional file 1: of Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people
147. Additional file 1 of Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection
148. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells
149. Predictors of Severe Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C.
150. Inoculation Herpes Simplex Virus Infections in Patients with AIDS: Unusual Appearance and Location of Lesions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.